Table 1 Population Characteristics.

From: Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer

N°

Gleason (X + X)

Tumor localization

TNM

nADC M0

PSA M0

MRI (T)

(1)

7 (4 + 3)

PZ

T2a

1.09

5.6

1.5

(2)

7 (4 + 3)

PZ

T2b

0.49

5.26

3

(3)

6 (3 + 3)

PZ

T1c

1.53

9.72

3

(4)

6 (3 + 3)

PZ

T2a

0.76

9.88

3

(5)

7 (3 + 4)

PZ

T1c

1.31

11.55

3

(6)

7 (4 + 3)

CZ

T2a

1.46

6

3

(7)

6 (3 + 3)

CZ

T2a

1.36

12.02

3

(8)

7 (4 + 3)

PZ

T2a

1.10

5.33

3

(9)

6 (3 + 3)

NA

T2b

1.19

5.96

3

(10)

7 (3 + 4)

TZ

T1c

1.35

10.07

3

(11)

6 (3 + 3)

PZ

T1c

1.04

17.67

3

(12)

7 (3 + 4)

NA

T2b

0.70

8.86

3

  1. N°: Identification number of patients; Gleason: Gleason score (Addition of the two most frequent gleason score population); TNM: TNM staging; MRI: type of MRI machine; PSA: prostate specific antigen in ng/ml; M0: Time of diagnosis; nADC: normalized apparent coefficient value in 10−3 mm2/s; –: no value available; Tumor localization: PZ for peripheral zone, TZ for transition zone and CZ for central zone. NA if tumor invaded more than one localization; Magnetic Resonance Imaging field (Tesla).
Back to article page